CVRx Analyst Ratings
Lake Street Maintains Buy on CVRx, Lowers Price Target to $12
Analysts Offer Insights on Healthcare Companies: Perrigo Company (PRGO) and CVRx (CVRX)
Piper Sandler Remains a Buy on CVRx (CVRX)
CVRx Analyst Ratings
JPMorgan Downgrades CVRx to Neutral From Overweight, Adjusts Price Target to $13 From $36
Lake Street Sticks to Their Buy Rating for CVRx (CVRX)
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL) and CVRx (CVRX)
Analysts' Top Healthcare Picks: CVRx (CVRX), DocGo (DCGO)
Piper Sandler Keeps Their Buy Rating on CVRx (CVRX)
Craig-Hallum Remains a Buy on CVRx (CVRX)
Lake Street Sticks to Their Buy Rating for CVRx (CVRX)
CVRx Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), CVRx (CVRX) and Capricor Therapeutics (CAPR)
Analysts Offer Insights on Healthcare Companies: Cellectar Biosciences (CLRB), Ionis Pharmaceuticals (IONS) and CVRx (CVRX)
Lake Street Adjusts CVRx Price Target to $35 From $32, Maintains Buy Rating
Craig-Hallum Keeps Their Buy Rating on CVRx (CVRX)
CVRx's Strong Q4 Performance and Positive 2024 Outlook Justify Buy Rating
Lake Street Maintains Buy on CVRx, Raises Price Target to $32
CVRx Analyst Ratings